EyePoint Pharmaceuticals Financial Overview
EyePoint Pharmaceuticals's market cap is currently $1.44B. The company's EPS TTM is $-0.85; its P/E ratio is -5.83; EyePoint Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
